Xcout Intel
Qureator, Inc.
Founded in 2020 and headquartered in San Diego, California, with additional offices in Seoul, South Korea, Qureator is a biomedical startup company. The company focuses on biotechnology research and development, having secured significant venture funding.
Subscribe to see Qureator, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Qureator, Inc. at a glance
Qureator, Inc. is a microphysiological systems company headquartered in United States. It has raised at least $21.7M across the 2 funding rounds on record. Its most recent funding round raised $6.7M in December 2025. Xcout tracks 10 named people at Qureator, Inc., including Kyusuk Baek (CEO).
Qureator, Inc. leadership
- Kyusuk BaekCEO
- Tsung-Li LiuChief Technology Officer
- Branka MitrovicChief Scientific Officer
- Paul ParkChief Business Officer
- Kyu BaekCo-founder, Chief Executive Officer
- Noo Li JeonCo-founder
4 more named people on record for Qureator, Inc., with roles, board committees and tenure — see the full roster →
Qureator, Inc. funding rounds
At least $21.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6.7M | — | |
| Series A | $15M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Qureator, Inc. competitors
A few of Qureator, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cquesta is a privately held agricultural biotechnology company headquartered in San Diego, California. Founded in 2022, the company develops climate-resilient crops designed to improve farmer productivity while actively combating climate change.
Arkgen Bioscions is a South Korean immuno-oncology startup headquartered in Daejeon. The company recently raised a $6.67 million Series A funding round to advance its proprietary biotech research. It focuses on developing innovative biopharmaceutical treatments.
ExoCoBio Co., Ltd. is a biotechnology research and regenerative medicine company founded in 2017 and headquartered in Seoul, South Korea. The company specializes in developing exosome-based therapeutics and cosmetic solutions.
Createrna, Inc. is an innovative biopharmaceutical company dedicated to the discovery and development of treatments for immunology, respiratory, and cardiovascular diseases. The company focuses its research pipeline on addressing complex chronic conditions through targeted therapeutic approaches. Their portfolio highlights early-stage pharmaceutical developments in specialized medical fields.
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
Get Qureator, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Qureator, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access